Navigation Links
Clarient Announces Fourth Quarter and Year-End 2007 Financial Results
Date:3/31/2008

Quarterly Revenue and Case Volumes Increase 53% and 52% Respectively

Year-over-Year

ALISO VIEJO, Calif., March 31 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced financial results for the fourth quarter and year ended December 31, 2007. Revenue from continuing operations was $12.4 million for the fourth quarter of 2007, an increase of over 53 percent compared to $8.1 million for the comparable period in 2006.

Total patient case volume for the fourth quarter of 2007 was approximately 21,500, an increase of 52 percent compared to the comparable period in 2006. Sequential total patient test volume in comparison to the third quarter of 2007 increased 10 percent, including a 6 percent increase in breast prognostics/solid tumor testing, an 18 percent increase in leukemia/lymphoma volumes, and a 12 percent increase in PCR/molecular testing volumes.

Clarient reported $6.4 million in gross profit for the fourth quarter of 2007, an increase of 78 percent as compared to $3.6 million for the comparable period in 2006. Reported gross margin in the fourth quarter of 2007 was 52 percent as compared to 45 percent for the same period 2006. Gross margins improved as a result of increased total patient volume, better use of the Company's capacity, improved revenue mix, improved process efficiencies and improved pricing with vendors.

Commenting on the year end results, Ron Andrews, President and CEO, said, "Our business model continued to validate that we can produce sustainable growth as we completed the quarter with a 53 percent increase in revenue over the fourth qua
'/>"/>

SOURCE Clarient, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
2. Clarient to Commercialize Novel Breast Cancer Profile
3. CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL)
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 2014  United Therapeutics Corporation (NASDAQ: ... its second quarter 2014 financial results before market ... United Therapeutics will host a half-hour teleconference on ... Time.  The teleconference is accessible by dialing 1-877-351-5881, ... the teleconference will be available for one week ...
(Date:7/22/2014)... PLAINS, New Jersey , 22. Juli 2014 ... für die Life-Sciences-Industrie, hat die Ernennung von Marcus ... bekanntgegeben. Herr Bergler hat die europäischen kommerziellen ... Lösungen unterstützt. Bevor er sich Qforma anschloss, war ... bei Cegedim Customer Information, als Vertriebsteam-Leiter Deutschland bei ...
(Date:7/22/2014)... Sunnyvale, CA (PRWEB) July 22, 2014 ... begin on September 9th, 2014 and will comprise of ... and Application’ classes. The TechTrainings is a series of ... professionals, designed to help them reach the next step ... SAS class is taught by Jennifer Kang, Senior ...
(Date:7/21/2014)... July 21, 2014 Lawrence ... Investment Board (WIB) and Las Positas College (LPC) ... technical education and hands-on training for veterans, officials ... Program at Las Positas is designed to ... for engineering technician careers, and establishes a pipeline ...
Breaking Biology Technology:Qforma gibt Schaffung des neuen Postens als General Manager in Europa bekannt 2Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 2Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 3Engineering Program Established for Veterans 2Engineering Program Established for Veterans 3
... Insurance are recruiting information technology workers to ... Valley earlier next year. , ,The Stevens Point-based insurer plans ... a rich pool of talent in the area and improvements ... to Appleton and other Fox Valley communities. ...
... radio frequency identification can improve the speed and ... at the University of Wisconsin-Madison is partnering ... is being called an "end-to-end" research project. , ,The project, ... transfusion, involves the Blood Center of Wisconsin , ...
... - The first segment of a national and international ... the announcement that CellCura, Inc. , a Norwegian biotechnology ... in Madison's University Research Park . , ,CellCura, the ... during the past two years, chose Madison following an international ...
Cached Biology Technology:RFID pilot project aims to improve blood banks 2RFID pilot project aims to improve blood banks 3CellCura could start an invasion of stem cell firms 2CellCura could start an invasion of stem cell firms 3
(Date:7/22/2014)... for the average steak, but it seems to help ... Alaska,s winter cold. , "Alaska wood frogs spend more ... in your freezer and the frog comes back to ... steak," said Don Larson, University of Alaska Fairbanks graduate ... that freeze tolerance in Alaska wood frogs is more ...
(Date:7/22/2014)... the survival rates of 12 different shark species ... operations found large differences in survival,rates across the ... hammerhead being the most,vulnerable. The study, led by ... School of,Marine and Atmospheric Science and UM Abess ... to consider for future conservation measures for sharks ...
(Date:7/22/2014)... could be on the horizon. Bacteria that produce ... gain, insulin resistance and other adverse effects of ... have discovered., "Of course it,s hard to speculate ... Davies, Ph.D., assistant professor of Pharmacology. "But essentially ... obesity in mice, even though they,re eating a ...
Breaking Biology News(10 mins):Alaska frogs reach record lows in extreme temperature survival 2Alaska frogs reach record lows in extreme temperature survival 3New study reveals vulnerability of sharks as collateral damage in commercial fishing 2Vanderbilt study shows therapeutic bacteria prevent obesity in mice 2
... pond, a grassland, a mountain range or on the entire ... range of estimates for the planet,s biodiversity, predicted to be ... way of estimating species richness reported this month in the ... ecologist John Harte and colleagues, will make such estimates more ...
... The HUGO Journal in cooperation with the Human Genome ... The HUGO Journal has a new design, new ... will receive free access to the journal online and be ... The HUGO Journal will focus on discoveries arising from ...
... latest-generation DNA sequencing technology to become the first explorers ... "This project is one of the first attempts to ... than a single organism," says Nicole Gerardo, assistant professor ... we can understand how these ants have evolved to ...
Cached Biology News:New theory gives more precise estimates of large-scale biodiversity 2New theory gives more precise estimates of large-scale biodiversity 3Landmark project to map genomics of complex ant systems 2
Human plasmacytoid dendritic cells, BDCA-4+, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
Umbilical cord blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Umbilical cord blood CD4+ T cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
Human peripheral blood CD56+ NK cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Biology Products: